• Patent Title: Method of treating diabetes mellitus by administration, at specifically defined intervals, of a derivative of a naturally occurring insulin or insulin analogue, the derivative having a prolonged profile of action
  • Application No.: US15810680
    Application Date: 2017-11-13
  • Publication No.: US10596229B2
    Publication Date: 2020-03-24
  • Inventor: Thue Johansen
  • Applicant: Novo Nordisk A/S
  • Applicant Address: DK Bagsvaerd
  • Assignee: Novo Nordisk A/S
  • Current Assignee: Novo Nordisk A/S
  • Current Assignee Address: DK Bagsvaerd
  • Agent Rosemarie R. Wilk-Orescan
  • Priority: EP10189115 20101027; EP11170366 20101027
  • Main IPC: A61K38/28
  • IPC: A61K38/28 C07K14/62
Method of treating diabetes mellitus by administration, at specifically defined intervals, of a derivative of a naturally occurring insulin or insulin analogue, the derivative having a prolonged profile of action
Abstract:
The present invention relates to methods for treatment of a condition or disease where administration of insulin will be of benefit, comprising administering, to a patient in need thereof, effective dosages of an insulin, insulin analogue or derivative thereof, which exhibits a prolonged profile of action, wherein said dosages are administered at intervals of varying length.
Information query
Patent Agency Ranking
0/0